Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis.
[read the full story...]Improving outcomes for people with first episode psychosis
No Responses »
Antipsychotic effectiveness: the numbers don’t lie, check the scoreboard
Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia.
[read the full story...]Risk factors and peripheral biomarkers for schizophrenia spectrum disorders
Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.
[read the full story...]Antidepressants for depression in schizophrenia: when good-enough evidence is good enough
Carmine Pariante is positive about a recent systematic review and meta-analysis of antidepressants for the treatment of depression in schizophrenia.
[read the full story...]Antipsychotic combinations for schizophrenia: safe and effective?
Elena Marcus presents the findings of an updated Cochrane review on antipsychotic combinations for schizophrenia.
[read the full story...]Personal well-being networks for severe mental illness: the importance of being social
The University College London Mental Health Masters students summarise a recent exploratory study on personal well-being networks, social capital and severe mental illness.
[read the full story...]#UnderstandingPsychosis?
Sameer Jauhar and Paul Morrison consider the revised Understanding Psychosis and Schizophrenia report from the British Psychological Society Division of Clinical Psychology, which includes updated sections on definitions, aetiology and treatment.
[read the full story...]Antipsychotics for acute treatment of first episode schizophrenia
Elwira Lubos writes her debut blog on a recent systematic review with pairwise and network meta-analyses, looking at antipsychotic drugs for the acute treatment of patients with first episode schizophrenia.
[read the full story...]People with severe mental illness die younger and things are getting worse
Judith Harrison publishes her debut blog on a recent cohort study in the British Journal of Psychiatry, which shows that the “mortality gap” is increasing for people with bipolar disorder and schizophrenia.
[read the full story...]Should people with schizophrenia be offered depot antipsychotics as first line treatment?
Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.
[read the full story...]